Monoclonal Antibodies-A New Horizon in Alzheimer's Treatment.
作者信息
Kwon Hyuk Sung, Koh Seong-Ho
机构信息
Department of Neurology, Hanyang University College of Medicine, Seoul, Korea.
Department of Translational Medicine, Hanyang University Graduate School of Biomedical Science & Engineering, Seoul, Korea.
出版信息
J Clin Neurol. 2025 Jan;21(1):1-2. doi: 10.3988/jcn.2024.0527.
Abstract
摘要
相似文献
1
Monoclonal Antibodies-A New Horizon in Alzheimer's Treatment.单克隆抗体——阿尔茨海默病治疗的新视野。
J Clin Neurol. 2025 Jan;21(1):1-2. doi: 10.3988/jcn.2024.0527.
2
A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease.抗淀粉样蛋白β单克隆抗体治疗阿尔茨海默病的疗效和安全性的系统评价。
Expert Opin Biol Ther. 2024 Nov;24(11):1261-1269. doi: 10.1080/14712598.2024.2416947. Epub 2024 Nov 12.
3
Stress induced exacerbation of Alzheimer's disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and monoclonal amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-399885.纳米脑活素与单克隆淀粉样β肽抗体联合应用 5-HT6 受体拮抗剂 SB-399885 可阻止应激加重阿尔茨海默病脑病理
Int Rev Neurobiol. 2023;171:3-46. doi: 10.1016/bs.irn.2023.05.018. Epub 2023 Sep 16.
4
Monoclonal antibodies that target pathological assemblies of Abeta.靶向β淀粉样蛋白病理聚集体的单克隆抗体。
J Neurochem. 2007 Jan;100(1):23-35. doi: 10.1111/j.1471-4159.2006.04157.x. Epub 2006 Nov 20.
5
6
Updates on pharmacological treatment for Alzheimer's disease.阿尔茨海默病药物治疗的研究进展。
Neurol Neurochir Pol. 2024;58(2):150-160. doi: 10.5603/pjnns.96286. Epub 2023 Aug 22.
7
The Importance of Vaccines in Preventing Impending Alzheimer's Epidemic.
Rev Recent Clin Trials. 2025 Apr 14. doi: 10.2174/0115748871357356250325071712.
8
Amyloid beta peptide immunotherapy in Alzheimer disease.阿尔茨海默病中的β淀粉样肽免疫疗法。
Rev Neurol (Paris). 2014 Dec;170(12):739-48. doi: 10.1016/j.neurol.2014.10.003. Epub 2014 Nov 6.
9
At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact.照料者为早期阿尔茨海默病患者在家中进行甘特钠单抗给药：可行性、安全性和药效学影响。
J Prev Alzheimers Dis. 2024;11(3):537-548. doi: 10.14283/jpad.2024.60.
10
Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease.健康受试者和阿尔茨海默病患者中抗 tau 单克隆抗体 JNJ-63733657 的 1 期研究。
J Prev Alzheimers Dis. 2024;11(6):1592-1603. doi: 10.14283/jpad.2024.163.
引用本文的文献
1
Nationwide Survey on the Awareness of Mild Cognitive Impairment.全国轻度认知障碍知晓情况调查
Dement Neurocogn Disord. 2025 Jul;24(3):198-207. doi: 10.12779/dnd.2025.24.3.198. Epub 2025 Jul 17.
本文引用的文献
1
Potential Benefits of Using Artificial Intelligence to Diagnose Alzheimer's Disease.使用人工智能诊断阿尔茨海默病的潜在益处。
J Clin Neurol. 2024 Sep;20(5):548-549. doi: 10.3988/jcn.2024.0288.
2
Predicting the Progression of Mild Cognitive Impairment to Alzheimer's Dementia Using Recurrent Neural Networks With a Series of Neuropsychological Tests.使用带有一系列神经心理学测试的递归神经网络预测轻度认知障碍向阿尔茨海默病痴呆症的进展
J Clin Neurol. 2024 Sep;20(5):478-486. doi: 10.3988/jcn.2023.0289.
3
Impact of Apolipoprotein E ε4 in Alzheimer's Disease: A Meta-Analysis of Voxel-Based Morphometry Studies.载脂蛋白Eε4在阿尔茨海默病中的影响：基于体素形态学研究的荟萃分析
J Clin Neurol. 2024 Sep;20(5):469-477. doi: 10.3988/jcn.2024.0176.
4
Alterations of Structural Network Efficiency in Early-Onset and Late-Onset Alzheimer's Disease.早发型和晚发型阿尔茨海默病中结构网络效率的改变
J Clin Neurol. 2024 May;20(3):265-275. doi: 10.3988/jcn.2023.0092. Epub 2024 Feb 5.
5
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
6
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
7
Could drugs prevent Alzheimer's? These trials aim to find out.药物能预防阿尔茨海默病吗？这些试验旨在找出答案。
Nature. 2022 Mar;603(7900):216-219. doi: 10.1038/d41586-022-00651-0.
Zotero 插件